Technology Immune Modulatory Small Molecules for the Treatment of Sepsis and Autoimmune Diseases Tumor necrosis factor alpha (TNFα) is an important cytokine that activates cell death programs in response to acute inflammation. TNFα inhibitors are currently used to treat a multitude of autoimmune…
Technology Self-assembling Nanofibril Particles for Controlled Release of IV and SUBQ Therapeutics Clinically approved methods for the controlled release of oral therapies have demonstrated their efficacy in reducing required dosage, administration frequency, and side effects, thereby boosting patient compliance. Despite these successes,…
Technology Lymphangiogenesis For Therapeutic Immunomodulation A vaccine platform that uses engineered lymphangiogenesis factors and antigens to stimulate lymphatic endothelial cells, creating strong, long-lasting immune memory or tolerance with fewer side effects than traditional vaccines The…
Technology FOXP3 Stapled Peptides to Deactivate Regulatory T Cells Regulatory T cells (Tregs) modulate immune function by preventing autoreactive T cell responses, including those that would normally target cancer cells. Treg activity can significantly limit the efficacy of immunotherapies…
Technology Sulfur-Containing Organic-Inorganic Hybrid Materials Organic‐inorganic hybrid sulfur‐containing materials show promising properties for a variety of applications (e.g., superconductors, thermoelectrics, etc.). Efficient synthesis of such compounds—especially those containing dithiolene‐type ligands—has historically been challenging due to…
Technology New System for the Synthesis of Silicon-Based Materials for Biological Modulation Pure silicon materials with strong photoelectrochemical properties are advantageous to biomodulations devices due to their excellent dielectric properties that are promising in many electrical transmission applications. Synthesis of such materials…
Technology New Class of Biocompatible and Flexible Optoelectronic Devices For Next Generation Pacemakers Electrode-based electrical stimulation underpins several clinical bioelectronic devices, including deep brain stimulators and cardiac pacemakers. Pacemaker therapy improves quality of life and reduces mortality rates. Despite significant advances, current pacemaker…
Technology Conformation-Specific Genetically Encodable Intrabodies for Spatially Modulating Protein Kinase Signaling Genetically encoded synthetic antibody fragments, expressed intracellularly, to specifically bind the mTOR FKBP12-Rapamycin binding domain inhibiting mTORC1 and mTORC2 activity. Fused with localization signals, these tools enable precise, compartment-specific modulation…
Technology Prolactin Receptor Antibodies For Targeted Cancer Therapy And Diagnosis Novel antibodies precisely targeting cancer cells by binding to the Prolactin Receptor (PRLR) to diagnose cancer, direct immune cells to destroy tumors, and inhibit cancer growth signals, without affecting healthy…
Technology Lithium-Driven Neural Inhibition Devices For Chronic Pain And Local Anesthesia An implantable bioelectronic device platform enabling targeted, programmable inhibition of neural activity through lithium ion delivery, offering durable local anesthesia and pain relief without systemic toxicity The Unmet Need: Programmable…
News The Polsky Center Announces the 20 Startups Selected for India Deep Tech Accelerator The Polsky Center for Entrepreneurship and Innovation today announced the 20 startups selected to join the inaugural cohort of the India Deep Tech Accelerator, a global accelerator designed to help high-potential, Indian...
Technology A Modular LOX-Mediated Delivery Platform for Solid Tumor Immunotherapy Enhanced tumor regression and immune activation through localized retention of engineered cytokines and chemokines by lysyl oxidase-mediated crosslinking to the tumor extracellular matrix improves therapeutic efficacy while reducing systemic toxicity.…